April 25th 2024
A recent study revealed a significant increase in intrauterine device usage among reproductive-aged women in South Carolina following the implementation of the Choose Well initiative.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Third Generation OC's: Safety and Indications for Use
August 4th 2011Third Generation OC's: Safety and Indications for UseSlide 2 of 26Slide 3 of 26Slide 4 of 26Slide 5 of 26Slide 6 of 26Slide 7 of 26Slide 8 of 26Slide 9 of 26Slide 10 of 26Slide 11 of 26Slide 12 of 26Slide 13 of 26Slide 14 of 26Slide 15 of 26Slide 16 of 26Slide 17 of 26Slide 18 of 26Slide 19 of 26Slide 20 of 26Slide 21 of 26Slide 22 of 26Slide 23 of 26Slide 24 of 26Slide 25 of 26Slide 26 of 26
Read More
Hormone-related Risk Factors for Breast Cancer in Women Under Age 50 Years
August 3rd 2011It has been suggested that hormonal risk factors act predominantly on estrogen receptor and progesterone receptor (ER/PR)-positive breast cancers. However, the data have been inconsistent, especially in younger women.
Read More
New role for tamoxifen as fertility drug for breast cancer patients?
August 3rd 2011In a study published today in Europe's leading reproductive medicine journal Human Reproduction1, researchers from New York's Cornell University report the first IVF pregnancy to result from the use of tamoxifen as an ovarian stimulant.
Read More
Minimizing Breast Pain: Recommendations
August 3rd 2011Sore breasts can signal the onset of PMS -- that 'ouch' feeling tells some women they're premenstrual more reliably than a calendar. Cyclical breast soreness shouldn't cause concern, according to Women's Health America. However, breast pain doesn't have to be tolerated. Here's how to minimize discomfort, and how to recognize cautionary signs that should send you to your doctor.
Read More
Transdermal Contraceptive System: Clinical Management
August 3rd 2011Disclosure Declaration •Grant Support –National Institutes of Health, Ortho-McNeil Pharmaceutical, Inc, Pharmacia Corp., Berlex Laboratories, Proctor and Gamble •Honoraria and consultation fees –Ortho-McNeil Pharmaceutical, Inc., Berlex Laboratories, Pharmacia Corp., TAP Pharmaceuticals, Eli Lilly and Co. •Participation in company sponsored speakers’ bureau –Ortho-McNeil Pharmaceutical, Inc., Berlex Laboratories, Pharmacia Corp., Merck Pharmaceuticals.
Read More
Intra Uterine Contraceptive Devices (I.U.C.D.)
August 3rd 2011Presented by Dr. Narayan M. Patel M.D., D.G.O. FICSEmeritus Professor Muni. Medical collegePostal address-Mahalaxmi Institute of Medical Teaching,3, Shantiniketan park, Naranpura,Nr. Sardar Patel Colony,AHMEDABAD- 380 014 (Gujarat) INDIA E mail:- nmpatel1932@wilnetonline.net
Read More
Gestational Trophoblastic Disease (GTD) Part I: Molar Pregnancy
August 3rd 2011Definitions Gestational Trophoblastic Neoplasia (GTN)=Malignant Gestational Trophoblastic DiseaseIt is a spectrum of trophoblastic diseases that develops malignant sequelae. GTN includes: • Persistent post molar GTD • Invasive mole • Choriocarcinoma • Placental site trophoblastic tumourThe last 2 may follow abortion, ectopic or normal pregnancy.Disaia &Creasman Clinical Gynecological Oncology 2007 Cunningham et al Williams Obsterics 23rd , 2010
Read More
Oral Contraceptives: Risks, Benefits & New Regimes
August 3rd 2011ORAL CONTRACEPTIVES: . Objectives . Know the risks, benefits and side effects of oral contraceptives . Utilize basic concepts in OC prescribing . Know how to modify regiments to manage side effects .Objectives .Know the risks, benefits and side effects of oral contraceptives .Utilize basic concepts in OC prescribing .Know how to modify regiments to manage side effects
Read More
A New Contraceptive Option: A Focus on the Transdermal Contraceptive System
A New Contraceptive Option: A Focus on the Transdermal Contraceptive System Ronald T. Burkman, MD Baystate Medical Center Tufts University School of Medicine
Read More